ABP
ABP
NASDAQ · Biotechnology

Abpro Holdings Inc

$0.12
-0.02 (-15.69%)
As of Mar 31, 5:00 PM ET ·
Financial Highlights (FY 2026)
Revenue
2.73M
Net Income
-107,722,981
Gross Margin
Profit Margin
-3,951.9%
Rev Growth
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 47.1% 47.1% 47.1%
Operating Margin -5,326.8% 5.8% 6.6% 6.6%
Profit Margin -3,951.9% 3.7% 4.4% 5.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.73M 1.55M 1.36M 1.68M
Gross Profit 728.7K 642.1K 792.6K
Operating Income -145,175,156 89.5K 90.2K 110.7K
Net Income -107,722,981 56.6K 59.8K 87.7K
Gross Margin 47.1% 47.1% 47.1%
Operating Margin -5,326.8% 5.8% 6.6% 6.6%
Profit Margin -3,951.9% 3.7% 4.4% 5.2%
Rev Growth -6.9% +10.8% +11.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 970.3K 829.5K 910.4K
Total Equity 1.39M 1.41M 1.26M
D/E Ratio 0.70 0.59 0.72
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -100,826,423 150.2K 130.3K 163.2K
Free Cash Flow 63.5K 61.7K 63.4K